NEW YORK, Sept. 3, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Analysis of the U.S. Obesity Surgery Devices Market
http://www.reportlinker.com/p0961313/Analysis-of-the-US-Obesity-Surgery-Devices-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment
This research service considers products and companies in the obesity surgery devices market in the United States. The market is expected to see many technology advancements in the next decade. Therefore, a thorough understanding of revenue forecasts, unit forecasts, technological advances, and pricing analyses are provided for the market's various segments including: gastric banding, gastric stimulators, and intragastric balloons. Furthermore, market engineering measurements, drivers, and restraints are covered along with an analysis of the market's highly competitive landscape. The base year is 2011; the forecast period extends through 2016.
Executive Summary
•Total revenue generated by sales of obesity surgery devices in the United States in 2011 was approximately $ xx million, representing a xx percent increase over 2010.
•Revenue in the U.S. obesity surgery devices market is projected to grow at a compound annual growth rate (CAGR) of xx percent from 2011 to 2016, reaching $ xx million in 2016.
•In 2011, only gastric banding was approved in the United States. Going forward, newer technologies such as intragastric balloons and gastric stimulators are expected to be launched.
•The company generating the highest revenue in the U.S. therapeutic surfaces market in 2011 was Allergan. The other company in this space is Ethicon Endo-Surgery.
•Rising obesity and increasing published literature on the risks of obesity are the main contributors to the overall market growth. Also, comorbidities associated with obesity such as diabetes and cardiovascular diseases are on the rise.
TABLE OF CONTENTS
Executive Summary 4
Market Overview 9
Total Market -
External Challenges: Drivers and Restraints 17
Forecasts and Trends 27
Market Share and Competitive Analysis 34
Gastric Banding Segment Breakdown 37
Gastric Stimulators Segment Breakdown 47
Intragastric Balloons Segment Breakdown 57
Emerging Companies and Technologies Segment Breakdown 65
The Last Word (Conclusions and Implications) 72
Appendix 78
To order this report:
Surgical_Equipment Industry: Analysis of the U.S. Obesity Surgery Devices Market
Contact Nicolas: [email protected]US: (805)-652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
Advertisement
Analysis of the U.S. Obesity Surgery Devices Market
http://www.reportlinker.com/p0961313/Analysis-of-the-US-Obesity-Surgery-Devices-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment
Advertisement
This research service considers products and companies in the obesity surgery devices market in the United States. The market is expected to see many technology advancements in the next decade. Therefore, a thorough understanding of revenue forecasts, unit forecasts, technological advances, and pricing analyses are provided for the market's various segments including: gastric banding, gastric stimulators, and intragastric balloons. Furthermore, market engineering measurements, drivers, and restraints are covered along with an analysis of the market's highly competitive landscape. The base year is 2011; the forecast period extends through 2016.
Executive Summary
•Total revenue generated by sales of obesity surgery devices in the United States in 2011 was approximately $ xx million, representing a xx percent increase over 2010.
•Revenue in the U.S. obesity surgery devices market is projected to grow at a compound annual growth rate (CAGR) of xx percent from 2011 to 2016, reaching $ xx million in 2016.
•In 2011, only gastric banding was approved in the United States. Going forward, newer technologies such as intragastric balloons and gastric stimulators are expected to be launched.
•The company generating the highest revenue in the U.S. therapeutic surfaces market in 2011 was Allergan. The other company in this space is Ethicon Endo-Surgery.
•Rising obesity and increasing published literature on the risks of obesity are the main contributors to the overall market growth. Also, comorbidities associated with obesity such as diabetes and cardiovascular diseases are on the rise.
TABLE OF CONTENTS
Executive Summary 4
Market Overview 9
Total Market -
External Challenges: Drivers and Restraints 17
Forecasts and Trends 27
Market Share and Competitive Analysis 34
Gastric Banding Segment Breakdown 37
Gastric Stimulators Segment Breakdown 47
Intragastric Balloons Segment Breakdown 57
Emerging Companies and Technologies Segment Breakdown 65
The Last Word (Conclusions and Implications) 72
Appendix 78
To order this report:
Surgical_Equipment Industry: Analysis of the U.S. Obesity Surgery Devices Market
Contact Nicolas: [email protected]US: (805)-652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
